Literature DB >> 19584622

Retinal vascular occlusion syndromes.

Jonathan G Haymore1, Luis J Mejico.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19584622     DOI: 10.1097/IIO.0b013e3181a8db88

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  10 in total

1.  Function-first ligandomics for ocular vascular research and drug target discovery.

Authors:  Xin Rong; Hong Tian; Liu Yang; Wei Li
Journal:  Exp Eye Res       Date:  2019-03-21       Impact factor: 3.467

2.  The risk of retinal vein occlusion among patients with neovascular age related macular degeneration: a large-scale cohort study.

Authors:  Orly Weinstein; Mouhammad Kridin; Khalaf Kridin; Oran Mann; Arnon D Cohen; Ofira Zloto
Journal:  Eye (Lond)       Date:  2022-07-01       Impact factor: 3.775

3.  Similarities and differences in systemic risk factors for retinal artery occlusion and retinal vein occlusion: A nationwide case-control study.

Authors:  Marie Ørskov; Henrik Vorum; Torben Bjerregaard Larsen; Gregory Y H Lip; Toke Bek; Flemming Skjøth
Journal:  Int Ophthalmol       Date:  2022-09-02       Impact factor: 2.029

Review 4.  Anti-vascular endothelial growth factor indications in ocular disease.

Authors:  Stefan Cornel; Iliescu Daniela Adriana; Timaru Cristina Mihaela; Schmitzer Speranta; De Simone Algerino; Batras Mehdi; Hosseini-Ramhormozi Jalaladin
Journal:  Rom J Ophthalmol       Date:  2015 Oct-Dec

5.  Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

6.  Central retinal artery occlusion in Wegener's granulomatosis: a diagnostic dilemma.

Authors:  Virginia Lozano-López; Beatriz Rodríguez-Lozano; María José Losada-Castillo; Esmeralda Delgado-Frías; David Dopazo-Luque; Miguel Serrano-García
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-02-24

7.  Practical management of retinal vein occlusions.

Authors:  Carlo La Spina; Umberto De Benedetto; Maurizio Battaglia Parodi; Gabriel Coscas; Francesco Bandello
Journal:  Ophthalmol Ther       Date:  2012-08-09

8.  Aflibercept in branch retinal vein occlusion as second line therapy: clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab-a pilot study.

Authors:  Magdalena A Wirth; Matthias D Becker; Nicole Graf; Stephan Michels
Journal:  Int J Retina Vitreous       Date:  2016-08-23

9.  Risk of retinal artery occlusion in patients with diabetes mellitus: A retrospective large-scale cohort study.

Authors:  Yuh-Shin Chang; Chung-Han Ho; Chin-Chen Chu; Jhi-Joung Wang; Sung-Huei Tseng; Ren-Long Jan
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

Review 10.  Anti-VEGF Therapy and the Retina: An Update.

Authors:  Vikas Tah; Harry O Orlans; Jonathan Hyer; Edward Casswell; Nizar Din; Vishnu Sri Shanmuganathan; Louise Ramskold; Saruban Pasu
Journal:  J Ophthalmol       Date:  2015-08-31       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.